MENU
BCAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Bicara Therapeutics (BCAX) Ownership - Who owns Bicara Therapeutics?

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
635.11M
P/E Ratio
N/A
Total Cash
462.07M
Projected Growth
N/A
Total Debt
591K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.47
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

BCAX
Capitalization
635M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
462M
Total Cash/Share
8.47
Total Debt
591K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
459M
P/B Ratio
1.46
Cash Flow
N/A
Earnings
-1.69
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
24.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-108.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.31
Shares Held By Institutions
735M
Shares Outstanding - Current
54.6M
Total Liabilities
19.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-33.180
View a ticker or compare two or three
BCAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details